Coherus Oncology, Inc. Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments
Coherus Oncology, Inc. (CHRS) reported Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments of $82.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments · last filed 2023-11-06
- Coherus Oncology, Inc. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2023-09-30 was $82.00K.
- Coherus Oncology, Inc. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2023-06-30 was $41.00K.
- Coherus Oncology, Inc. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2023-03-31 was -$123.00K.
| Period end | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 3 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 6 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 9 month |
|---|---|---|---|
| 2023-09-30 | $82.00K 10-Q · filed 2023-11-06 | $123.00K derived: sum of 2 quarters · filed 2023-11-06 | $0.00 derived: sum of 3 quarters · filed 2023-11-06 |
| 2023-06-30 | $41.00K 10-Q · filed 2023-08-02 | -$82.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | -$123.00K 10-Q · filed 2023-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |